{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:45:42Z","timestamp":1782128742594,"version":"3.54.5"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.atherosclerosis.2014.12.002","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T23:48:28Z","timestamp":1419032908000},"page":"289-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Expression of anaphylatoxin receptors on platelets in patients with coronary heart disease"],"prefix":"10.1016","volume":"238","author":[{"given":"J.","family":"Patzelt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.L.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Breuning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Karathanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Schleicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Seizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.F.","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/CIRCULATIONAHA.113.002870","article-title":"Nanoparticle-mediated delivery of pitavastatin inhibits atherosclerotic plaque destabilization\/rupture in mice by regulating the recruitment of inflammatory monocytes","volume":"129","author":"Katsuki","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib3","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1084\/jem.20012044","article-title":"A\u00a0critical role of platelet adhesion in the initiation of atherosclerotic lesion formation","volume":"196","author":"Massberg","year":"2002","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib4","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1172\/JCI27196","article-title":"Platelets in inflammation and atherogenesis","volume":"115","author":"Gawaz","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nm810","article-title":"Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E","volume":"9","author":"Huo","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/10739680802564787","article-title":"Platelet-mediated enhancement of leukocyte adhesion","volume":"16","author":"von Hundelshausen","year":"2009","journal-title":"Microcirculation"},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35393","article-title":"CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells","volume":"391","author":"Henn","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib8","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1182\/blood-2010-01-261206","article-title":"Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis","volume":"116","author":"Lievens","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib9","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/359848a0","article-title":"Leukocyte accumulation promoting fibrin deposition is mediated in\u00a0vivo by P-selectin on adherent platelets","volume":"359","author":"Palabrica","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-2007-969029","article-title":"Platelets and stromal cell-derived factor-1 in progenitor cell recruitment","volume":"33","author":"Stellos","year":"2007","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.atherosclerosis.2011.09.022","article-title":"Plasma levels of stromal cell-derived factor-1 in patients with coronary artery disease: effect of clinical presentation and cardiovascular risk factors","volume":"219","author":"Stellos","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/eurheartj\/eht448","article-title":"Expression of stromal cell-derived factor-1 receptors CXCR4 and CXCR7 on circulating platelets of patients with acute coronary syndrome and association with left ventricular functional recovery","volume":"35","author":"Rath","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib13","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/303810a0","article-title":"A\u00a0new function for platelets: IgE-dependent killing of schistosomes","volume":"303","author":"Joseph","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/256125a0","article-title":"Endotoxin-sensitive membrane component of human platelets","volume":"256","author":"Hawiger","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1538-7836.2010.04172.x","article-title":"Complement in atherosclerosis: friend or foe?","volume":"9","author":"Speidl","year":"2011","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0002-9149(02)02498-0","article-title":"Evidence for complement activation in ruptured coronary plaques in acute myocardial infarction","volume":"90","author":"Laine","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib17","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1096\/fj.10-174284","article-title":"Complement C5a inhibition reduces atherosclerosis in ApoE-\/- mice","volume":"25","author":"Manthey","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib18","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/CIRCULATIONAHA.110.954370","article-title":"C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice","volume":"122","author":"Shagdarsuren","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib19","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/01.CIR.0000087447.12918.85","article-title":"Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial","volume":"108","author":"Granger","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib20","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1161\/01.CIR.100.25.2499","article-title":"Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass","volume":"100","author":"Fitch","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1586\/14779072.4.5.649","article-title":"The use of TP10, soluble complement receptor 1, in cardiopulmonary bypass","volume":"4","author":"Li","year":"2006","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4049\/jimmunol.138.1.254","article-title":"Cellular distribution of complement receptor type 4 (CR4): expression on human platelets","volume":"138","author":"Vik","year":"1987","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1084\/jem.158.2.603","article-title":"Human platelet activation by C3a and C3a des-arg","volume":"158","author":"Polley","year":"1983","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib24","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0019-2791(77)90351-2","article-title":"Studies on the mode of reaction of the first component of complement with platelets: interaction between the collagen-like portion of C1q and platelets","volume":"14","author":"Wautier","year":"1977","journal-title":"Immunochemistry"},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib25","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib26","first-page":"2","article-title":"Recommendations guiding physicians in biomedical research involving human subjects","volume":"35","author":"World Medical Association Declaration of Helsinki","year":"1997","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib27","first-page":"45","article-title":"ICH harmonized tripartite guideline: guideline for good clinical practice","volume":"47","author":"International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use","year":"2001","journal-title":"J.\u00a0Postgrad. Med."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib28","first-page":"12","volume":"9","year":"2002","journal-title":"Med. Etika Bioet."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib29","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2008.11.030","article-title":"Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis","volume":"53","author":"Sibbing","year":"2009","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib30","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1213\/ane.0b013e31818524c1","article-title":"Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study","volume":"107","author":"Velik-Salchner","year":"2008","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.atherosclerosis.2010.07.023","article-title":"Impact of inflammatory markers on platelet inhibition and cardiovascular outcome including stent thrombosis in patients with symptomatic coronary artery disease","volume":"213","author":"Muller","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1160\/TH08-10-0669","article-title":"Cross validation of the multiple electrode aggregometry. A prospective trial in healthy volunteers","volume":"102","author":"Siller-Matula","year":"2009","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib33","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood-2011-12-398438","article-title":"Intracellular cyclophilin A is an important Ca(2+) regulator in platelets and critically involved in arterial thrombus formation","volume":"120","author":"Elvers","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib34","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/eurheartj\/ehn566","article-title":"Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells","volume":"30","author":"Stellos","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib35","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1468-1331.2011.03527.x","article-title":"Expression of stromal-cell-derived factor-1 (SDF-1): a predictor of ischaemic stroke?","volume":"19","author":"Wurster","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib36","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa031688","article-title":"Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria","volume":"350","author":"Hillmen","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib37","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1182\/blood-2010-01-261503","article-title":"Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis","volume":"116","author":"Langer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib38","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/01.ATV.0000127302.24266.40","article-title":"Lack of complement factor C3, but not factor B, increases hyperlipidemia and atherosclerosis in apolipoprotein E-\/- low-density lipoprotein receptor-\/- mice","volume":"24","author":"Persson","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib39","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1161\/01.CIR.0000019584.04929.83","article-title":"Influence of C3 deficiency on atherosclerosis","volume":"105","author":"Buono","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib40","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cell.2005.06.015","article-title":"Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets","volume":"122","author":"Denis","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib41","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1083\/jcb.200105058","article-title":"Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis","volume":"154","author":"Lindemann","year":"2001","journal-title":"J.\u00a0Cell. Biol."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib42","doi-asserted-by":"crossref","DOI":"10.1160\/TH13-02-0102","article-title":"Crosstalk between platelets and the complement system in immune protection and disease","volume":"110","author":"Langer","year":"2013","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib43","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1161\/01.CIR.0000028590.02477.6F","article-title":"Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury","volume":"106","author":"Schober","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib44","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1182\/blood-2008-01-078204","article-title":"The vessel wall and its interactions","volume":"111","author":"Wagner","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib45","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1084\/jem.20041497","article-title":"Platelet activation leads to activation and propagation of the complement system","volume":"201","author":"Del Conde","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib46","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/1042819021000037985","article-title":"The regulation of hematopoietic stem cell and progenitor mobilization by chemokine SDF-1","volume":"44","author":"Hattori","year":"2003","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijcard.2011.06.082","article-title":"Platelet expression of stromal-cell-derived factor-1 (SDF-1): an indicator for ACS?","volume":"164","author":"Wurster","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib48","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/01.RES.86.2.131","article-title":"The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques","volume":"86","author":"Abi-Younes","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib49","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.4049\/jimmunol.162.12.7426","article-title":"Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets","volume":"162","author":"Ekdahl","year":"1999","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib50","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0167-5699(91)90012-I","article-title":"The response of human platelets to activated components of the complement system","volume":"12","author":"Sims","year":"1991","journal-title":"Immunol. Today"},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jtcvs.2010.08.035","article-title":"Effects of C5 complement inhibitor pexelizumab on outcome in high-risk coronary artery bypass grafting: combined results from the PRIMO-CABG I and II trials","volume":"142","author":"Smith","year":"2011","journal-title":"J.\u00a0Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib52","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1517\/14712598.5.6.833","article-title":"Pexelizumab \u2013 a C5 complement inhibitor for use in both acute myocardial infarction and cardiac surgery with cardiopulmonary bypass","volume":"5","author":"Fleisig","year":"2005","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.atherosclerosis.2014.12.002_bib53","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/nbt1342","article-title":"Complement-targeted therapeutics","volume":"25","author":"Ricklin","year":"2007","journal-title":"Nat. Biotechnol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014016086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014016086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T20:31:17Z","timestamp":1690749077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915014016086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0021915014016086"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.12.002","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of anaphylatoxin receptors on platelets in patients with coronary heart disease","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}